Vijaya Diagnostic Centre share price
NSE: VIJAYABSE: 543350Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,390.80.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹14,311 Cr523rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 76.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 7 May 2026
- 15.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 21.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 27.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 7 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,59,08557.1% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 6 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹231 Crup 5.29%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹53 Crup 10.79%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 23.0%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 7 Nov | Dec 2024Filed 12 Feb | Mar 2025Filed 10 Jun | Jun 2025Filed 28 Jul | Sep 2025Filed 4 Nov | Dec 2025Filed 13 Feb | Mar 2026Filed 7 May | Jun 2026Filed 6 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 | 202 | 205 | 219 | 231 |
| Net profit | 42 | 35 | 35 | 39 | 43 | 43 | 48 | 53 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 23.0% | 20.9% | 20.1% | 20.5% | 21.5% | 21.0% | 21.8% | 23.0% |
Business segments
In the year to Mar 2026 the company reports one business segment, Diagnostic Services, which carries all its revenue.
Valuation
Today, against the company's own history.PE ratio and valuation history
At or below today's level on 81% of 1,086 trading days since Jun 2022.
At or below today's level on 90% of 1,229 trading days since Nov 2021.
At or below today's level on 79% of 1,086 trading days since Jun 2022.
At or below today's level on 48% of 1,229 trading days over the last 5 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −14.2% | +20.5% | −29.0% | 0.2% |
| 3 years | +30.3% | +26.6% | +2.8% | 0.2% |
Mutual funds holding it
107 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 48 of the 59 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 2
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 21
- CutCut. Funds that held fewer shares than at the end of the month before.
- 38
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 45
| Fund | |||
|---|---|---|---|
| 54,54,656 | 4.10% | ₹784.2 Cr | |
| 46,16,178 | 1.63% | ₹663.7 Cr | |
| 29,13,646 | 0.78% | ₹418.9 Cr | |
| 25,03,558 | 1.94% | ₹359.9 Cr | |
| 20,61,599 | 0.97% | ₹296.4 Cr | |
| 16,71,618 | 2.62% | ₹240.3 Cr | |
| 12,89,654 | 0.74% | ₹185.4 Cr | |
| 12,37,085 | 2.14% | ₹177.9 Cr | |
| 9,87,292 | 1.88% | ₹141.9 Cr | |
| 7,37,748 | 3.11% | ₹106.1 Cr |
Peers and competitors
Healthcare Service Provider, 36 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Vijaya Diagnostic Centre in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 30,854 | 56.9 | 12.3 | 35.7 | +14.3% | +5.6% | 23.2% | 26.2% | 0.87% | |
| 10,849 | 53.8 | 7.2 | 25.6 | +21.8% | +32.6% | 14.2% | 18.6% | 0.38% | |
| 7,372 | 41.8 | 12.6 | 25.9 | +21.1% | +65.7% | 31.1% | 37.9% | 2.02% | |
| 5,998 | – | 5.4 | – | – | – | – | – | 0.00% | |
| 1,617 | 16.6 | 1.6 | 8.2 | +10.2% | +21.5% | 10.5% | 8.0% | 0.40% | |
| 1,559 | 43.6 | 6.4 | 15.0 | +23.3% | +8.1% | 15.7% | 24.0% | 0.17% | |
| 1,145 | 20.6 | 3.5 | 19.6 | +54.3% | +13.2% | 18.7% | 14.1% | 0.37% | |
| 849 | – | 1.3 | – | +28.8% | – | −3.1% | −9.4% | 0.00% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.| Ex-date | Type | Per share |
|---|---|---|
| 16 Sep 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
| 29 Aug 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
| 30 Aug 2024 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 13 Sep 2023 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 20 Sep 2022 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
2 Sep · Analysts
Vijaya Diagnostic Centre share price by year
Each calendar year to 2025.Vijaya Diagnostic Centre share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,061.00 | +0.4% | 1,241.80 | 891.20 |
| 2024 | 1,056.85 | +56.4% | 1,219.65 | 604.35 |
| 2023 | 675.70 | +54.6% | 675.70 | 352.25 |
| 2022 | 437.15 | −25.0% | 598.75 | 300.40 |
| 2021 | 582.50 | – | 644.05 | 510.85 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 1,394.00 | 1,406.40 | 1,360.30 | 1,389.40 | 1,387.59 | 1,59,085 | 57.1% |
| 22 Oct 2026 | 1,335.20 | 1,398.00 | 1,335.00 | 1,390.80 | 1,383.14 | 1,08,077 | 38.9% |
| 21 Oct 2026 | 1,368.20 | 1,373.80 | 1,337.30 | 1,353.40 | 1,350.36 | 85,007 | 60.2% |
| 19 Oct 2026 | 1,370.00 | 1,378.00 | 1,354.70 | 1,368.20 | 1,367.83 | 1,84,487 | 62.3% |
| 16 Oct 2026 | 1,387.40 | 1,395.90 | 1,354.20 | 1,381.70 | 1,368.21 | 3,83,691 | 72.3% |
| 15 Oct 2026 | 1,411.00 | 1,415.90 | 1,372.10 | 1,387.40 | 1,385.80 | 1,33,378 | 44.9% |
| 14 Oct 2026 | 1,407.20 | 1,433.50 | 1,400.00 | 1,402.20 | 1,408.68 | 77,909 | 59.7% |
| 13 Oct 2026 | 1,440.00 | 1,451.90 | 1,395.00 | 1,406.50 | 1,409.32 | 1,23,137 | 54.7% |
| 12 Oct 2026 | 1,442.10 | 1,458.80 | 1,424.80 | 1,452.10 | 1,447.88 | 72,392 | 54.7% |
| 9 Oct 2026 | 1,423.00 | 1,452.00 | 1,417.60 | 1,436.60 | 1,437.14 | 47,126 | 49.9% |
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited runs diagnostic centres and laboratories that offer pathology and radiology tests. It serves individuals, clinicians and institutions. It also provides corporate wellness programmes that combine health check-ups with specialised diagnostic packages for employers. It was incorporated in 2002 and is headquartered in Hyderabad.
The company brings pathology and radiology together on a single platform, so a patient can have both kinds of tests at one centre. Its imaging equipment includes 3T MRI, advanced CT scanners, digital PET-CT and gamma cameras. Central and reference laboratories work together with a hub-and-spoke network of centres, in which large laboratories process samples collected at smaller centres. Patients can book appointments online and use home sample collection. Its laboratories hold NABL accreditation, a national quality standard for testing laboratories.
The company operates centres in Andhra Pradesh, Telangana, West Bengal, Maharashtra, Karnataka and Gurgaon. It opened its first centre under the Vijaya brand in Kolkata. In Bengaluru, it launched hub centres at Yelahanka and HSR Layout under the Vijaya brand. It entered the Pune market by acquiring a 100% stake in P.H. Diagnostics. Its shares are listed on the NSE and BSE.
The company is led by its promoter, Dr Sura Surendranath Reddy, who is its executive chairman. A promoter is the person or group that set up a company or controls it.
- Legal name
- Vijaya Diagnostic Centre Limited
- NSE symbol
- VIJAYA
- BSE code
- 543350
- ISIN
- INE043W01024
- Industry
- Healthcare Services
- Listed
- Sep 2021
- Face value
- ₹1
- CIN
- L85195TG2002PLC039075
- Corporate identity number, the registrar of companies' code for it